Aralez Pharmaceuticals (ARZ) Trading -2.3% Higher
Aralez Pharmaceuticals Inc (TSE:ARZ) shares traded up 2.3% during trading on Thursday . The stock traded as high as C$2.19 and last traded at C$2.12. 12,539 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 53,007 shares. The stock had previously closed at C$2.17.
The firm has a market cap of $119.61 and a P/E ratio of -1.34.
COPYRIGHT VIOLATION WARNING: “Aralez Pharmaceuticals (ARZ) Trading -2.3% Higher” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://www.thecerbatgem.com/2018/01/11/aralez-pharmaceuticals-arz-trading-2-3-higher.html.
Aralez Pharmaceuticals Company Profile
Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.
Receive News & Ratings for Aralez Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.